# GLUL

## Overview
The GLUL gene encodes the enzyme glutamate-ammonia ligase, commonly known as glutamine synthetase, which is a critical enzyme in nitrogen metabolism. This enzyme catalyzes the conversion of glutamate and ammonia into glutamine, playing a vital role in ammonia detoxification and maintaining nitrogen balance within the body. Glutamine synthetase is categorized as a ligase due to its function in forming a new chemical bond between molecules. It is predominantly active in the liver, brain, and muscle tissues, where it supports various physiological processes, including neurotransmitter recycling and acid-base homeostasis. The enzyme's activity is essential for preventing ammonia toxicity and is particularly significant in the brain's glutamate-glutamine cycle, where it helps regulate neurotransmitter levels (Zhou2020Novel; Häberle2005Congenital; Griffin2018In).

## Structure
The GLUL protein, also known as glutamate-ammonia ligase, is an enzyme that catalyzes the synthesis of glutamine from glutamate and ammonia. Its primary structure consists of a sequence of amino acids forming the polypeptide chain. The secondary structure of GLUL includes alpha-helices and beta-sheets, contributing to its overall stability and function (Frieg2016Molecular). The tertiary structure is a three-dimensional conformation stabilized by interactions such as hydrogen bonds and disulfide bridges, which are crucial for maintaining the enzyme's active conformation (Frieg2016Molecular).

GLUL often forms a quaternary structure as a homodecamer, composed of two pentameric rings, which is essential for its enzymatic activity (Frieg2016Molecular). This multimeric assembly allows for the formation of a bifunnel-shaped catalytic site, which is critical for substrate binding and catalysis (Frieg2016Molecular). The enzyme's activity can be influenced by post-translational modifications, such as phosphorylation, which may regulate its function under different physiological conditions (Frieg2016Molecular). The GLUL gene also exhibits splice variant isoforms, which may have distinct regulatory roles or tissue-specific expressions, although specific details on these variants are not extensively covered in the provided context (Dhanasiri2012Glutamine).

## Function
The GLUL gene encodes the enzyme glutamine synthetase, which plays a crucial role in ammonia detoxification and nitrogen metabolism by catalyzing the conversion of glutamate and ammonia into glutamine. This process is essential for maintaining nitrogen balance and preventing ammonia toxicity in the body (Zhou2020Novel; Griffin2018In). Glutamine synthetase is highly active in the liver, brain, and muscle, where it supports various physiological functions, including ammonia detoxification, interorgan nitrogen flux, and acid-base homeostasis (Häberle2005Congenital).

In the brain, glutamine synthetase is primarily located in astrocytes, where it is involved in the glutamate-glutamine cycle, a key pathway for recycling neurotransmitters. This enzyme helps maintain the balance of excitatory and inhibitory neurotransmission by converting excess glutamate into glutamine, which can then be used to synthesize neurotransmitters such as glutamate and GABA (Suárez2002Glutamine; Zhou2020Novel). In the liver, glutamine synthetase is expressed in perivenous hepatocytes, where it contributes significantly to ammonia detoxification, particularly in the absence of a functional urea cycle (Griffin2018In). The enzyme's activity is also linked to the regulation of acid-base balance and cellular energy homeostasis (Palmieri2017Pharmacologic).

## Clinical Significance
Mutations in the GLUL gene, which encodes the enzyme glutamine synthetase, are associated with several severe clinical conditions. Congenital glutamine synthetase deficiency, caused by homozygous mutations such as R324C and R341C, leads to severe brain malformations, multiorgan failure, and neonatal death. These mutations result in reduced enzyme activity, leading to the absence of glutamine in serum, urine, and cerebrospinal fluid, while glutamate levels remain normal. This deficiency is characterized by neurological compromise, cardiac insufficiency, and multiorgan failure, with significant brain abnormalities like immature brain development, enlarged ventricles, and agyria (Häberle2005Congenital).

Alterations in GLUL expression are also implicated in neurological diseases. In mesial temporal lobe epilepsy (MTLE), a pronounced loss of glutamine synthetase is observed in the hippocampus, particularly in areas with significant neuronal loss and astroglial proliferation. This deficiency is linked to increased extracellular glutamate levels, contributing to excitotoxicity and seizure generation. The downregulation of glutamine synthetase, rather than a lack of glutamate transporters, is suggested to impair glutamate clearance, highlighting its role in maintaining glutamate homeostasis (Eid2004Loss).


## References


[1. (Palmieri2017Pharmacologic) Erika M. Palmieri, Alessio Menga, Rosa Martín-Pérez, Annamaria Quinto, Carla Riera-Domingo, Giacoma De Tullio, Douglas C. Hooper, Wouter H. Lamers, Bart Ghesquière, Daniel W. McVicar, Attilio Guarini, Massimiliano Mazzone, and Alessandra Castegna. Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an m1-like phenotype and inhibits tumor metastasis. Cell Reports, 20(7):1654–1666, August 2017. URL: http://dx.doi.org/10.1016/j.celrep.2017.07.054, doi:10.1016/j.celrep.2017.07.054. This article has 241 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2017.07.054)

[2. (Frieg2016Molecular) Benedikt Frieg, Boris Görg, Nadine Homeyer, Verena Keitel, Dieter Häussinger, and Holger Gohlke. Molecular mechanisms of glutamine synthetase mutations that lead to clinically relevant pathologies. PLOS Computational Biology, 12(2):e1004693, February 2016. URL: http://dx.doi.org/10.1371/journal.pcbi.1004693, doi:10.1371/journal.pcbi.1004693. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pcbi.1004693)

[3. (Zhou2020Novel) Yun Zhou, Tore Eid, Bjørnar Hassel, and Niels Christian Danbolt. Novel aspects of glutamine synthetase in ammonia homeostasis. Neurochemistry International, 140:104809, November 2020. URL: http://dx.doi.org/10.1016/j.neuint.2020.104809, doi:10.1016/j.neuint.2020.104809. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.neuint.2020.104809)

[4. (Häberle2005Congenital) Johannes Häberle, Boris Görg, Frank Rutsch, Eva Schmidt, Annick Toutain, Jean-François Benoist, Antoinette Gelot, Annie-Laure Suc, Wolfgang Höhne, Freimut Schliess, Dieter Häussinger, and Hans G. Koch. Congenital glutamine deficiency with glutamine synthetase mutations. New England Journal of Medicine, 353(18):1926–1933, November 2005. URL: http://dx.doi.org/10.1056/nejmoa050456, doi:10.1056/nejmoa050456. This article has 164 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1056/nejmoa050456)

[5. (Griffin2018In) Jeddidiah W. D. Griffin, Ying Liu, Patrick C. Bradshaw, and Kesheng Wang. In silico preliminary association of ammonia metabolism genes gls, cps1, and glul with risk of alzheimer’s disease, major depressive disorder, and type 2 diabetes. Journal of Molecular Neuroscience, 64(3):385–396, February 2018. URL: http://dx.doi.org/10.1007/s12031-018-1035-0, doi:10.1007/s12031-018-1035-0. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12031-018-1035-0)

[6. (Eid2004Loss) T Eid, MJ Thomas, DD Spencer, E Rundén-Pran, JCK Lai, GV Malthankar, JH Kim, NC Danbolt, OP Ottersen, and NC de Lanerolle. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. The Lancet, 363(9402):28–37, January 2004. URL: http://dx.doi.org/10.1016/s0140-6736(03)15166-5, doi:10.1016/s0140-6736(03)15166-5. This article has 338 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0140-6736(03)15166-5)

[7. (Dhanasiri2012Glutamine) Anusha K.S. Dhanasiri, Jorge M.O. Fernandes, and Viswanath Kiron. Glutamine synthetase activity and the expression of three glul paralogues in zebrafish during transport. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 163(3–4):274–284, November 2012. URL: http://dx.doi.org/10.1016/j.cbpb.2012.06.003, doi:10.1016/j.cbpb.2012.06.003. This article has 22 citations.](https://doi.org/10.1016/j.cbpb.2012.06.003)

[8. (Suárez2002Glutamine) I. Suárez, G. Bodega, and B. Fernández. Glutamine synthetase in brain: effect of ammonia. Neurochemistry International, 41(2–3):123–142, August 2002. URL: http://dx.doi.org/10.1016/s0197-0186(02)00033-5, doi:10.1016/s0197-0186(02)00033-5. This article has 291 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0197-0186(02)00033-5)